Its mechanism of action closely resembles Semaglutides, making it a suitable alternative for those who may not respond well to one or the other
Research models suggest the combination maintains endocrine specificity, making it of interest to investigators focused on isolating GH-axis effects without confounding stress-hormone elevations
Your local Fast Pace primary care team is here to guide you every step of the way
Common adverse effects reported by participants who took the highest dose of retatrutide in the TRIUMPH-1 trial included nausea (42.4% of participants), diarrhoea (32.0% of participants), constipation (26.1% of participants) and vomiting (25.3% of participants)
Patients should be educated on proper injection technique, storage, and potential adverse effects
The 2025 Kuceki study demonstrated 26.5% hair regrowth with this combination approach